Market Overview

Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Acadia Pharmaceuticals, Inc.


Federman & Sherwood announces that on July 19, 2018, a class action
lawsuit was filed in the United States District Court for the Southern
District of California against Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD). The complaint alleges violations of federal securities laws,
Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule
10b-5, including allegations of issuing a series of material or false
misrepresentations to the market which had the effect of artificially
inflating the market price during the Class Period, which is April 29,
2016 through July 9, 2018.

Plaintiff seeks to recover damages on behalf of all Acadia
Pharmaceuticals, Inc. shareholders who purchased common stock during the
Class Period and are therefore a member of the Class as described above.
You may move the Court no later than Monday, September 17, 2018 to serve
as a lead plaintiff for the entire Class. However, in order to do so,
you must meet certain legal requirements pursuant to the Private
Securities Litigation Reform Act of 1995.

If you wish to discuss this action, obtain further information and
participate in this or any other securities litigation, or should you
have any questions or concerns regarding this notice or preservation of
your rights, please contact:

Robin Hester
10205 North Pennsylvania
Oklahoma City, OK 73120
Email to:
visit the firm's website at

View Comments and Join the Discussion!